Patent ID: 7427482
Filing Date: 2008-09-23
Classification: A01K,A61K,C12N,C12Q,G01N

Abstract:
1. A method of determining whether a human individual is at an increased risk for developing sporadic prostate cancer comprising the steps of: a) obtaining a biological sample comprising a nucleic acid from said human individual; b) determining the identity of a biallelic marker at position 22906 of SEQ ID NO: 1 (A7) and position 379 of SEQ ID NO: 19 (A29) within said biological sample; and c) evaluating whether said human individual is at an increased risk of sporadic prostate cancer; wherein the presence of both an A at position 22906 of SEQ ID NO: 1 (A7) and an A at position 379 of SEQ ID NO: 19 (A29) is indicative of an increased risk for developing sporadic prostate cancer.